AngioDynamics (ANGO) Downgraded to “Hold” at Craig Hallum

AngioDynamics (NASDAQ:ANGO) was downgraded by Craig Hallum from a “buy” rating to a “hold” rating in a report issued on Friday, The Fly reports.

Other research analysts have also recently issued reports about the stock. Zacks Investment Research raised shares of AngioDynamics from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a report on Tuesday, October 3rd. TheStreet cut shares of AngioDynamics from a “b-” rating to a “c” rating in a report on Tuesday. Canaccord Genuity reaffirmed a “hold” rating and set a $17.00 target price on shares of AngioDynamics in a report on Sunday, October 8th. Finally, KeyCorp reaffirmed a “hold” rating on shares of AngioDynamics in a report on Friday, September 29th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $18.60.

AngioDynamics (ANGO) opened at $15.71 on Friday. The company has a current ratio of 2.34, a quick ratio of 1.48 and a debt-to-equity ratio of 0.17. AngioDynamics has a twelve month low of $14.80 and a twelve month high of $18.85. The firm has a market cap of $602.51, a P/E ratio of 104.74, a PEG ratio of 1.64 and a beta of 1.04.

AngioDynamics (NASDAQ:ANGO) last released its quarterly earnings data on Thursday, January 4th. The medical instruments supplier reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. AngioDynamics had a net margin of 1.64% and a return on equity of 4.83%. The firm had revenue of $86.70 million during the quarter, compared to analysts’ expectations of $88.15 million. During the same period in the previous year, the company earned $0.19 earnings per share. The firm’s quarterly revenue was down 2.6% on a year-over-year basis. analysts anticipate that AngioDynamics will post 0.67 EPS for the current fiscal year.

A number of hedge funds have recently made changes to their positions in the business. State of Alaska Department of Revenue boosted its position in shares of AngioDynamics by 91.7% in the second quarter. State of Alaska Department of Revenue now owns 6,768 shares of the medical instruments supplier’s stock worth $109,000 after purchasing an additional 3,238 shares during the period. Municipal Employees Retirement System of Michigan boosted its position in shares of AngioDynamics by 7.3% in the third quarter. Municipal Employees Retirement System of Michigan now owns 6,330 shares of the medical instruments supplier’s stock worth $111,000 after purchasing an additional 430 shares during the period. BNP Paribas Arbitrage SA boosted its position in shares of AngioDynamics by 99.2% in the second quarter. BNP Paribas Arbitrage SA now owns 8,174 shares of the medical instruments supplier’s stock worth $117,000 after purchasing an additional 4,071 shares during the period. Teachers Retirement System of The State of Kentucky boosted its position in shares of AngioDynamics by 77.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 7,100 shares of the medical instruments supplier’s stock worth $123,000 after purchasing an additional 3,100 shares during the period. Finally, Mason Street Advisors LLC boosted its position in shares of AngioDynamics by 8.5% in the first quarter. Mason Street Advisors LLC now owns 7,470 shares of the medical instruments supplier’s stock worth $130,000 after purchasing an additional 584 shares during the period. 95.23% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/05/angiodynamics-ango-downgraded-to-hold-at-craig-hallum.html.

AngioDynamics Company Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

The Fly

Analyst Recommendations for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply